Portfolio company
Mimio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Mimio develops biomimetic fasting supplements for consumers to support cellular health, metabolism and longevity without requiring dietary restriction.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bevimi
This company develops liquid nutritional supplements and diagnostic tools designed to support cognitive longevity and reduce neuroinflammation for individuals experiencing early cognitive decline.
Metabolize
This company develops dietary supplements for individuals managing weight after discontinuing or cycling off GLP-1 medications to help maintain muscle and regulate appetite.
Longevity Operating System
This platform provides biomarker monitoring, personalised health protocols, and nutritional products for consumers seeking to extend their healthspan.
Avea
This company manufactures longevity dietary supplements designed to support healthy ageing and cellular health for health-conscious consumers.
Elysium Health
This company develops and sells dietary supplements and biological age tests for consumers seeking to support cellular health and longevity.
Stealth Longevity Company
This company develops a metabolic health and preventative care platform for healthcare professionals to launch longevity-focused private practices.
AminoSense
This company develops a biosensor platform for real-time amino acid measurement at home to help consumers optimize protein nutrition and metabolic health.
BioLumen
BioLumen develops a structured fibre that absorbs sugars and fats to reduce calorie intake for consumers and food manufacturers.
